Blue Sky Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-22,710	Closed	-$1.05M	–	101
2017 Q2	$1.05M	Sell	22,710 -5,206	-19%	-$240K	0.57%	38
2017 Q1	$1.21M	Buy	+27,916	New	+$1.21M	0.73%	22